Medical Weight Loss8 min read

GLP-1 Weight-Loss Pills: The Wegovy Pill and Foundayo vs. Injections

This article reflects the FDA-approved labels and manufacturer announcements as of November 2026. Prices change often. It is educational and is not medical advice; whether any of these medicines is right for you is a decision to make with a licensed prescriber.

For most of the GLP-1 era, prescription weight-loss medicine meant a weekly shot. That changed in the past year. The FDA has now approved two once-daily pills for chronic weight management:

•Wegovy pill (oral semaglutide 25 mg, Novo Nordisk), approved December 22, 2025 and launched January 5, 2026.

•Foundayo (orforglipron, Eli Lilly), approved April 1, 2026 and launched April 9, 2026.

If you're considering a medical weight-loss program, a med spa or telehealth provider may now offer you a pill instead of an injection. Here is how they differ.

Two different kinds of pill

The Wegovy pill contains semaglutide, the same medicine as the Wegovy and Ozempic injections, in a tablet with an absorption enhancer. Foundayo contains orforglipron, a different, small-molecule medicine that also acts on the GLP-1 receptor. It isn't a pill version of an existing injection.

That difference shows up in how you take them.

How you take each one

Wegovy pill. Under the FDA label, you take one tablet each morning on an empty stomach with up to 4 ounces of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. The dose starts at 1.5 mg and goes up every 30 days (4 mg, then 9 mg) to a 25 mg maintenance dose. If you miss a dose, you skip it and take the next one the following day.

Foundayo. Under its FDA label, you take one tablet once a day, with or without food, at any time of day. The dose starts at 0.8 mg, goes to 2.5 mg and then 5.5 mg after at least 30 days each, and may be raised to 9 mg, 14.5 mg or 17.2 mg based on how you respond and tolerate it.

Wegovy injection. One injection a week, any time of day, with or without meals.

If a strict morning routine is hard for you, that's worth raising with your prescriber. If you dislike needles, either pill removes the shot.

What the labels show for weight loss

These numbers come from different trials with different patients and lengths, so they can't be compared head to head. Each is the average change for all randomized patients in people without diabetes, with diet and exercise counseling:

•Wegovy pill 25 mg: −13.6% at 64 weeks (placebo −2.4%).

•Foundayo 17.2 mg, the highest dose: −11.1% at 72 weeks (placebo −2.1%).

•Wegovy injection 2.4 mg: −14.9% at 68 weeks (placebo −2.4%).

On Foundayo's lower doses, average loss was smaller: −7.4% on 5.5 mg and −8.3% on 9 mg in the same trial. Results vary widely from person to person.

Side effects and warnings

All three share the class profile. The most common side effects are gastrointestinal: nausea, diarrhea, vomiting and constipation, especially as the dose goes up. All three labels carry a boxed warning about thyroid C-cell tumors seen in rodents and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. The labels also warn about pancreatitis, gallbladder problems, low blood sugar when combined with some diabetes medicines, and the risk of aspiration during anesthesia or sedation, so tell any surgeon or anesthesiologist you take one.

Two label points specific to the pills:

•Birth control. Foundayo's label advises women using oral contraceptives to switch to a non-oral method, or add a barrier method, for 30 days after starting and after each dose increase.

•Other pills. Both pills slow stomach emptying, which can change how other oral medicines are absorbed. The Wegovy pill's 30-minute wait exists for that reason. Bring a full medication list to your appointment.

You shouldn't take two GLP-1 medicines at once, and the labels say so.

What they cost

Prices were set at launch for people paying cash, and both companies have changed prices since. As announced:

•Wegovy pill: $149 a month for the 1.5 mg starting dose; $149 for 4 mg through April 15, 2026, then $199; $299 a month for 9 mg and 25 mg. Novo Nordisk said commercially insured patients could pay as little as $25 a month with its savings offer.

•Foundayo: from $149 a month self-pay and from $25 a month with commercial coverage, according to Lilly.

Check the manufacturer's current self-pay price and your plan's coverage before you start. A clinic's program price may also include visits, labs and coaching, so ask what you're paying for.

Pills vs. compounded versions

FDA-approved pills change one part of the compounded GLP-1 story. After the FDA declared the semaglutide and tirzepatide shortages over, the legal room for compounding copies of those drugs narrowed sharply. Our guide to GLP-1 programs at med spas in 2026 explains what's legal now. If a clinic offers a "semaglutide pill" or "oral GLP-1" that isn't the Wegovy pill, Rybelsus or Foundayo, ask exactly what it is and where it comes from.

Questions to ask your prescriber

•Which medicine do you recommend for me, and why a pill or an injection?

•How will we raise the dose, and what happens if I can't tolerate a step?

•Does this interact with anything I take, including birth control and thyroid medicine?

•Is the medicine dispensed by a licensed pharmacy, and is it the FDA-approved product?

•What's the total monthly cost, and what's included?

•How will we plan for maintenance or stopping?

For more on how GLP-1 weight loss affects your face and skin, see our guide to Ozempic face.


This article is educational and does not constitute medical advice. Always consult a licensed medical professional for personalized recommendations.

Looking for a medical weight loss provider?